Table 1.
Demographic characteristics
| Pre-COVID-19 | COVID-19 period | p value | |
|---|---|---|---|
| Demographic characteristics | |||
| Stroke code activations, n | 532 | 546 | 0.669 |
| Thrombolysis | 157 (29.5) | 171 (31.3) | 0.415 |
| Female | 280 (53) | 326 (49) | 0.094 |
| Age | 67 (55–77) | 67 (55–77) | 0.406 |
| Medical history | |||
| Hypertension | 368 (69.1) | 461 (68.9) | 0.950 |
| Diabetes | 172 (32) | 209 (31) | 0.708 |
| Previous stroke | 119 (22.4) | 127 (18.9) | 0.151 |
| Active smoking | 73 (13.7) | 101 (15) | 0.510 |
| Atrial fibrillation | 52 (9.8) | 52 (7.8) | 0.256 |
| Previous myocardial infarction | 34 (6.4) | 46 (6.7) | 0.816 |
| Dyslipidemia | 34 (6.4) | 29 (4.3) | 0.119 |
| Stroke characteristics | |||
| Time in minutes to presentation since last known well | 107 (50–180) | 104 (55–170) | 0.581 |
| Proportion of participants with known time of the stroke onset, % | 95 | 97 | 0.346 |
| Stroke severity by the NIHSS | 5 (2–11) | 6 (2–13) | 0.055 |
| Hospital response characteristics, min | |||
| Door-to-needle time | 55 (44–67) | 58 (47–73) | 0.070 |
| Door-to-CT time | 12 (5–24) | 14 (6–27) | 0.114 |
| Door-to-VC time | 36 (25–50) | 36 (27–52) | 0.560 |
| Decision-making-to-needle time | 6 (4–10) | 5 (3–8) | 0.016 |
Data presented as n (%) or median (IQR).